343 related articles for article (PubMed ID: 22064478)
41. Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function.
Rangasamy V; Mishra R; Sondarva G; Das S; Lee TH; Bakowska JC; Tzivion G; Malter JS; Rana B; Lu KP; Kanthasamy A; Rana A
Proc Natl Acad Sci U S A; 2012 May; 109(21):8149-54. PubMed ID: 22566623
[TBL] [Abstract][Full Text] [Related]
42. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
[TBL] [Abstract][Full Text] [Related]
43. Prolyl isomerase PIN1 negatively regulates SGK1 stability to mediate tamoxifen resistance in breast cancer cells.
Jo A; Yun HJ; Kim JY; Lim SC; Choi HJ; Kang BS; Choi BY; Choi HS
Anticancer Res; 2015 Feb; 35(2):785-94. PubMed ID: 25667458
[TBL] [Abstract][Full Text] [Related]
44. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1.
Monje P; Hernández-Losa J; Lyons RJ; Castellone MD; Gutkind JS
J Biol Chem; 2005 Oct; 280(42):35081-4. PubMed ID: 16123044
[TBL] [Abstract][Full Text] [Related]
45. Pin1 deficiency causes endothelial dysfunction and hypertension.
Chiasson VL; Munshi N; Chatterjee P; Young KJ; Mitchell BM
Hypertension; 2011 Sep; 58(3):431-8. PubMed ID: 21810655
[TBL] [Abstract][Full Text] [Related]
46. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1.
Liu W; Youn HD; Zhou XZ; Lu KP; Liu JO
FEBS Lett; 2001 May; 496(2-3):105-8. PubMed ID: 11356192
[TBL] [Abstract][Full Text] [Related]
47. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT.
Stanya KJ; Liu Y; Means AR; Kao HY
J Cell Biol; 2008 Oct; 183(1):49-61. PubMed ID: 18838553
[TBL] [Abstract][Full Text] [Related]
48. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.
Siepe D; Jentsch S
Nat Cell Biol; 2009 Aug; 11(8):967-72. PubMed ID: 19597489
[TBL] [Abstract][Full Text] [Related]
49. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
[TBL] [Abstract][Full Text] [Related]
50. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
51. Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer.
Zheng XQ; Guo JP; Yang H; Kanai M; He LL; Li YY; Koomen JM; Minton S; Gao M; Ren XB; Coppola D; Cheng JQ
Oncogene; 2014 Oct; 33(42):4985-96. PubMed ID: 24166501
[TBL] [Abstract][Full Text] [Related]
52. Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins.
Rudrabhatla P; Albers W; Pant HC
J Neurosci; 2009 Nov; 29(47):14869-80. PubMed ID: 19940183
[TBL] [Abstract][Full Text] [Related]
53. Negative Regulation of Peptidyl-Prolyl Isomerase Activity by Interdomain Contact in Human Pin1.
Wang X; Mahoney BJ; Zhang M; Zintsmaster JS; Peng JW
Structure; 2015 Dec; 23(12):2224-2233. PubMed ID: 26602185
[TBL] [Abstract][Full Text] [Related]
54. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
55. Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1.
Innes BT; Sowole MA; Gyenis L; Dubinsky M; Konermann L; Litchfield DW; Brandl CJ; Shilton BH
Biochim Biophys Acta; 2015 May; 1852(5):905-12. PubMed ID: 25595659
[TBL] [Abstract][Full Text] [Related]
56. Interaction and structural modification of topoisomerase IIalpha by peptidyl prolyl isomerase, pin1: an in silico study.
Mathur R; Suman S; Beaume N; Ali M; Bhatt AN; Chopra M; Saluja D; Mishra AK; Chandna S; Kapoor PN; Dwarakanath BS
Protein Pept Lett; 2010 Feb; 17(2):151-63. PubMed ID: 20214639
[TBL] [Abstract][Full Text] [Related]
57. Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α.
Han HJ; Kwon N; Choi MA; Jung KO; Piao JY; Ngo HK; Kim SJ; Kim DH; Chung JK; Cha YN; Youn H; Choi BY; Min SH; Surh YJ
PLoS One; 2016; 11(1):e0147038. PubMed ID: 26784107
[TBL] [Abstract][Full Text] [Related]
58. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
[TBL] [Abstract][Full Text] [Related]
59. The prolyl isomerase Pin1 in breast development and cancer.
Wulf G; Ryo A; Liou YC; Lu KP
Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
[TBL] [Abstract][Full Text] [Related]
60. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
Kim G; Kim JY; Choi HS
Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
